Metcoloy 2, OSU 060

SECTION 2: Hazards identification

29 CFR 1910.1200) Emergency overview Physical state Solid. [Wire] Color : Gray. Odor : Odorless.

Signal word

WARNING!

Hazard statements

THESE WARNINGS PERTAIN PRIMARILY TO THE BYPRODUCTS PRODUCED DURING THERMAL SPRAY. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. CANCER HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE CANCER. DURING THERMAL SPRAY A PORTION OF CHROMIUM AND NICKEL MAY BE CONVERTED TO HEXAVALENT CHROMIUM AND NICKEL COMPOUNDS WHICH ARE KNOWN TO CAUSE CANCER.

Precautionary statements

Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.

Potential Acute Health Effects

Inhalation Irritating to respiratory system. Ingestion No known significant effects or critical hazards. Skin Irritating to skin. Eyes Irritating to eyes.

Potential chronic health

effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : Contains material which can cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: upper respiratory tract, skin, eye, lens or cornea. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing disorders involving any target organs mentioned in this SDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)